2-10-16-Multiple Endocrine Neoplasia Syndromes (Lopez) Flashcards
What is the most prevalent form of MEN?
Men1
MEN tumors arise from the ___ group of cells, which constitute the diffuse system of neuroendocrine cells distributed throughout the body
Amine Precursor Uptake Decarboxylation (APUD)
The APUD acronym denotes the capacity of these cells to synthesize and/or secrete biogenic amines formed through the activity of the enzyme ___
L-DOPA decarboxylase
What types of tumors are associated with MEN1?
Parathyroid adenoma (95%) Pancreatic endocrine tumors (50%) Pituitary adenomas (40%) Carcinoid tumors (30%)
What types of tumors are associated with MEN2A?
Medullary thyroid carcinoma (100%) Bilateral pheochromocytoma (50%) Parathyroid adenoma (10%)
What types of tumors are associated with MEN2B?
Medullary thyroid carcinoma (100%)
Neuromas (100%)
Pheochromocytoma (50%)
Marfanoid habitus and mucosal neuromas are characteristic of ___
MEN2B
___ is associated with possible Zollinger-Ellison and various pituitary pathologies such as acromegaly, cushing syndrome, and galactorrhea
MEN1
Wermer syndrome is caused by mutations in the MEN1 gene, which encodes a protein known as Menin. Menin functionally acts as a ____
Tumor suppressor
Mutations in menin causes unregulated cell division that leads to tumor formation
Tumors in the parathyroid, pancreas (endocrine), and pituitary are associated with ___
MEN1 (Wermer syndrome)
What are 3 means of diagnosing MEN1?
Clinical-2 or more MEN1-associated tumors
Familial-Patient with 1 MEN1-associated tumor and a 1st degree relative with MEN1
Genetic-An asymptomatic carrier of MEN1 mutation (no BCHEM manifestations)
___ is usually the 1st manifestation of MEN1
Hyperparathyroidism
___ is the 2nd most common manifestation of MEN1
Neoplastic transformation of the pancreatic islet cells
The most frequent manifestation of MEN1 pancreatic involvement is a ___
___ are the 2nd most common type of functional pancreatic tumor in MEN1
Gastrinoma
Insulinoma
The symptoms of ___ are the 3rd most common manifestation of MEN1
Hyperprolactinemia